Moves by developed nations such as the United States to tighten intellectual property laws are threatening to limit production and distribution of generic drugs, which experts say have been and will remain key in the prevention and treatment of HIV/AIDS and currently account for 80 percent of HIV/AIDS treatment. These efforts are taking shape in two spheres. The first is in discussions on the outcome document that member states are expected...
More »SEARCH RESULT
Total Matching Records found : 41
AID POLICY: Getting the recipe right for US food aid
-Irin Changing the food the US government supplies as aid could deliver better results and still save money, a new study says. The review for the US Agency for International Development (USAID) by researchers at the Tufts University Friedman School of Nutrition Science and Policy has been welcomed by NGOs and US food aid experts, but the findings have also come in for some criticism. The two-year review considered if USAID...
More »Need to maintain prices, supply of drug-resistant tuberculosis medicines: Médecins Sans Frontières by Aarti Dhar
As a new rapid diagnostic test, endorsed by the WHO, will finally help detect more people with DR-TB DR-TB medicines are very expensive Need to improve access to DR-TB drugs As a new rapid diagnostic test, endorsed by the World Health Organisation (WHO), will finally help detect more people with drug-resistant tuberculosis (DR-TB), there was need to solve problems around the pricing and supply of DR-TB medicines, according to a report by international...
More »India-EU generic drug row 'resolved' at Brussels summit
A row between the EU and India over the transit of generic drugs through Europe has been resolved, negotiators told Reuters news agency.As a result of the deal at an India-EU summit in Brussels, an Indian complaint to the World Trade Organization will be suspended, India's trade minister said.But some fear the free trade agreement (FTA) at the core of the summit will hurt generic drug production.The FTA, one of...
More »Pfizer conducted drug trials on Nigerian children, bullied its way out of lawsuit: WikiLeaks by Sarah Boseley
Pfizer tried a new antibiotic on 200 children, allegedly without sufficient documentation. When federal authorities pressed charges, the pharma giant hired investigators to probe attorney general Michael Aondoakaa's and put pressure on him to drop the federal cases.The world’s biggest pharmaceutical company hired investigators to unearth evidence of corruption against the Nigerian attorney general in order to persuade him to drop legal action over a controversial drug trial involving children...
More »
